XML 43 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:        
Net loss $ (769,333) $ (15,967)    
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Depreciation and amortization 34,127 38,102    
Provision for credit losses 2,498 5,881    
Share-based compensation 17,594 35,264    
Fair value and remeasurement adjustments, non-cash (includes $265,512 and $7,129 from related parties for 2024 and 2023, respectively) 261,357 (42,819)    
Non-cash interest and other (includes $(2,015) and $(1,821) from related parties for 2024 and 2023, respectively) (26,307) (9,440)    
Depreciation of rental merchandise 11,718 0    
Effect of foreign currency on operations (297) 686    
Loss (income) from equity investments (12) 175    
Dividends from equity investments 111 198    
Deferred income taxes 20,455 (21,394)    
Impairment of goodwill and tradenames 27,681 37,233    
Loss on disposal of discontinued operations 39,500 0    
Gain on sale of business, disposal of fixed assets, and other (723) (9,581)    
Loss on extinguishment of debt 5,780 5,294    
Income allocated and fair value adjustment for mandatorily redeemable noncontrolling interests 1,416 1,335    
Change in operating assets and liabilities:        
Amounts due to/from clearing brokers 19,467 3,853    
Securities and other investments owned 639,280 (43,289)    
Securities borrowed 2,806,935 (438,673)    
Accounts receivable 7,238 14,121    
Prepaid expenses and other assets (includes $8,565 and $(2,001) from related parties for 2024 and 2023, respectively) 23,031 1,282    
Accounts payable, accrued payroll and related expenses, accrued expenses and other liabilities (34,577) (30,024)    
Amounts due to/from related parties and partners (569) (1,235)    
Securities sold, not yet purchased (6,151) 1,223    
Deferred revenue (9,433) (11,941)    
Securities loaned (2,804,492) 438,759    
Net cash provided by (used in) operating activities 266,294 (40,957)    
Cash flows from investing activities:        
Purchases of loans receivable (includes $(16,259) and $(203,878) from related parties for 2024 and 2023, respectively) (79,913) (405,359)    
Repayments of loans receivable (includes $49,876 and $347,279 from related parties for 2024 and 2023, respectively) 105,331 543,633    
Sale of loans receivable 22,785 7,500    
Proceeds from loan participations sold 4,000 0    
Acquisition of businesses and minority interest, net of $604 and $772 cash acquired for 2024 and 2023, respectively (19,142) (15,276)    
Sale of business, net of cash sold and other 258 17,346    
Purchases of property, equipment and intangible assets (6,725) (5,782)    
Funds received from trust account of subsidiary 0 175,763    
Purchase of equity and other investments (1,065) (4,871)    
Net cash provided by investing activities 25,529 312,954    
Cash flows from financing activities:        
Proceeds from revolving line of credit 64,101 191,265    
Repayment of revolving line of credit (94,221) (261,697)    
Proceeds from note payable 15,000 0    
Repayment of notes payable and other (6,156) (11,853)    
Repayment of term loan (138,574) (504,246)    
Proceeds from term loan 0 628,187    
Proceeds from issuance of senior notes 0 185    
Redemption of senior notes (140,491) (58,924)    
Payment of debt issuance and offering costs (3,484) (27,188)    
Payment of contingent consideration (7,395) (1,884)    
ESPP and payment of employment taxes on vesting of restricted stock (3,136) (8,619)    
Common dividends paid (33,627) (110,959)    
Preferred dividends paid (6,045) (6,042)    
Repurchase of common stock 0 (53,688)    
Distribution to noncontrolling interests (4,560) (4,012)    
Contributions from noncontrolling interests 3,213 4,312    
Redemption of subsidiary temporary equity and distributions 0 (175,763)    
Proceeds from issuance of common stock 0 115,000    
Proceeds from issuance of preferred stock 0 467    
Proceeds from exercise of warrants 653 0    
Net cash used in financing activities (354,722) (285,459)    
Decrease in cash, cash equivalents and restricted cash (62,899) (13,462)    
Effect of foreign currency on cash, cash equivalents and restricted cash (1,092) (3,116)    
Net decrease in cash, cash equivalents and restricted cash (63,991) (16,578)    
Cash, cash equivalents and restricted cash from continuing operations, beginning of period 224,565 225,981    
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period 9,274 44,945    
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total 169,848 254,348 $ 233,839 $ 270,926
Cash, cash equivalents and restricted cash from continuing operations, end of period 160,613 226,431    
Cash, cash equivalents and restricted cash from discontinued operations, end of period 9,235 27,917    
Supplemental disclosures:        
Interest paid 205,421 231,874    
Taxes paid $ 5,818 $ 7,798